Another good day for the share price.
If Ralph and team can show Q on Q growth that exceeds their projections the share price should continue higher. The FDA announcements and any further acquisitions will be icing on the cake.
Also, Ralph has a busy schedule meeting investors and presenting around the world over the coming months. This should attract new investors.
@lightning70 In relation to the risk of someone developing a superior solution, while it could happen it would be a long way off due to Barriers to Entry, and by then VHT should have a dominant market share. Page 23 of the presentation highlights the Barriers to Entry:
VHT Price at posting:
$1.58 Sentiment: Buy Disclosure: Held
